Alzheimer's and Parkinson's Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study.

Yu, Yizhou; Travaglio, Marco; Popovic, Rebeka; Leal, Nuno Santos; Martins, Luis Miguel

Yu, Yizhou; Travaglio, Marco; Popovic, Rebeka; Leal, Nuno Santos; Martins, Luis Miguel.

Afiliación

Yu Y; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.
Travaglio M; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.
Popovic R; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.
Leal NS; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.
Martins LM; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.

Geriatrics (Basel) ; 6(1)2021 Jan 26.

Article en En | MEDLINE | ID: mdl-33530357

Palabras clave

Alzheimer's disease; COVID-19; Parkinson's disease; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Geriatrics (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google